Codexis Reschedules Second Quarter 2013 Financial Results
REDWOOD CITY, Calif. -- August 5, 2013
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced that the
company has rescheduled the release of its second quarter financial results
due to matters described in the company’s current report on Form 8-K filed
with the Securities and Exchange Commission after market close today. The
company will now release its second quarter financial results after market
close on Friday, August 9, 2013.
The company will host a live conference call and audio webcast on Thursday,
August 15, 2013 at 4:30 p.m. Eastern Time to discuss its second quarter 2013
financial results.A recorded version of the call will be available
approximately one hour after the call on the Investors section of the
company's website, www.codexis.com, and will be archived for up to 30 days.
What: Codexis' Second Quarter 2013 Financial Results Conference Call
Date: Thursday, August 15, 2013
Time: 4:30 p.m. ET
Live Call: US: 877-415-3177
Investors page of www.codexis.com
Replay: US: 888-286-8010
About Codexis, Inc.
Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical
production. Codexis’ proven technology enables scale-up and implementation of
biocatalytic solutions to meet customer needs for rapid, cost-effective and
sustainable process development – from research to manufacturing. For more
information, see www.codexis.com.
Paul Cox, 650-421-8331
Jemma Connor, +44 161 359 3255
Press spacebar to pause and continue. Press esc to stop.